Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations

Expert Review of Hematology
Helena Maes, Michel Delforge

Abstract

Multiple myeloma (MM) is a plasma cell neoplasm with a chronic disease course that primarily affects elderly individuals. The introduction of novel agents such as thalidomide, lenalidomide and bortezomib has significantly improved the outcome for MM patients, including the elderly. Quality of life in MM is influenced by disease-related symptoms, treatment-related toxicity and treatment response. In addition to conventional endpoints as response, quality of life should be carefully evaluated during each therapeutic phase. Caring for older adults with MM is particularly challenging because of the heterogeneity of aging and the presence of comorbidities and frailty, with a potential risk of over- or under-treatment. Moreover, elderly patients may sometimes prioritize maintaining quality of life above prolonging survival. A careful evaluation of comorbidities and a geriatric assessment can facilitate risk-stratification of elderly patients to identify the older population fit enough to tolerate standard drug dosing, and to detect the frail patients who need age-adapted treatment.

References

Mar 20, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Linda P FriedGerard Anderson
Jan 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominique DuboisChristine de la Loge
Apr 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigurdur Yngvi KristinssonMagnus Björkholm
Jun 19, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K CocksUNKNOWN EORTC Quality of Life Group
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Aug 18, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael SchaapveldEdo Vellenga
May 8, 2010·Blood·Anders WaageUNKNOWN Nordic Myeloma Study Group
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre WijermansUNKNOWN Dutch-Belgium Cooperative Group HOVON
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Mar 13, 2012·European Journal of Haematology·Martin HjorthUNKNOWN Nordic Myeloma Study Group (NMSG)
May 11, 2012·The New England Journal of Medicine·Antonio PalumboUNKNOWN MM-015 Investigators
Jan 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C KenisH Wildiers
Jul 3, 2013·Haematologica·Antonio CherubiniFabrizia Lattanzio
Aug 27, 2013·Leukemia·W J ChngUNKNOWN International Myeloma Working Group
Sep 11, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Erin E KentNeeraj K Arora
Oct 15, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Karin JordanFaith E Davies
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PalumboRobert Z Orlowski
Jan 18, 2014·Expert Review of Hematology·Evangelos TerposG David Roodman
Jul 6, 2014·Haematologica·Sonja ZweegmanPieter Sonneveld
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans WildiersArti Hurria
Aug 28, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sarah SlootSam H Ahmedzai
Sep 4, 2014·The New England Journal of Medicine·Lotfi BenboubkerUNKNOWN FIRST Trial Team
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Víctor M Castellano-MegíasFrancisco Colina-Ruizdelgado
Sep 19, 2014·World Journal of Gastrointestinal Oncology·María Del Carmen Gómez-MateoAntonio Ferrández-Izquierdo

❮ Previous
Next ❯

Citations

Aug 28, 2016·Journal of Geriatric Oncology·Nicolas Kint, Michel Delforge
May 4, 2016·The American Journal of Hospice & Palliative Care·Fiona KielyTony O'Brien
Nov 14, 2018·Expert Opinion on Pharmacotherapy·Paul G RichardsonSagar Lonial
Sep 26, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Katja WeiselHartmut Goldschmidt
Jul 19, 2019·Expert Review of Hematology·Pasquale NiscolaFabio Efficace
Jul 6, 2019·European Journal of Cancer Care·M Graça PereiraMargarida Vilaça
May 28, 2019·Current Oncology Reports·Crystal Antoine-Pepeljugoski, Marc Justin Braunstein
May 4, 2018·Journal of Health Psychology·M Graça PereiraGabriela Ferreira
Nov 22, 2020·Clinical Lymphoma, Myeloma & Leukemia·Monika EngelhardtAndrea Lebioda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Chiara CerratoAntonio Palumbo
Journal of the National Comprehensive Cancer Network : JNCCN
Charise GleasonSagar Lonial
Current Hematologic Malignancy Reports
Antonio PalumboMario Boccadoro
© 2022 Meta ULC. All rights reserved